Clarification of Eligibility for Institutions with Multiple Campuses in PAR-20-213 "National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)"
Notice Number:
NOT-GM-23-024

Key Dates

Release Date:

March 20, 2023 

Related Announcements

PAR-20-213 - National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to alert potential applicants of a clarification in the "Eligible Organizations" section of PAR-20-213, "National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)" regarding the eligibility of institutions with multiple campuses.

Part 2. Section III.3. Additional Information on Eligibility

Currently reads:

Number of Applications

Applicant organizations may submit more than one application, provided that each application is programmatically distinct. NIGMS accepts predoctoral training grant applications to enhance graduate research training in 12 broad areas of basic biomedical sciences. NIGMS will support only one training program in each training area per institution (normally identified by having a unique DUNS number or NIH IPF number).  Applicants are expected to identify the program area to which they are applying on the Cover Page (see below).

The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

Modified to read (changes in italics):

Number of Applications

Applicant organizations may submit more than one application, provided that each application is programmatically distinct. NIGMS accepts predoctoral training grant applications to enhance graduate research training in 12 broad areas of basic biomedical sciences. NIGMS will support only one training program in each training area per applicant organization (normally identified by having a Unique Entity Identifier (UEI) and a unique NIH eRA Institutional Profile File (IPF) number).  Applicants are expected to identify the program area to which they are applying on the Cover Page (see below).

Each application must be submitted by an eligible organization with a Unique Entity Identifier (UEI) and a unique NIH eRA Institutional Profile File (IPF) number. For institutions with multiple campuses, eligibility can be considered for an individual campus (e.g., main, satellite, etc.) as the applicant organization only if a UEI and a unique NIH eRA IPF number are established for the individual campus. For institutions that use one UEI or NIH IPF number for multiple campuses, eligibility as the applicant organization is determined for the campuses together.

The NIH will not accept duplicate or highly overlapping applications under review at the same time.  This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

All other aspects of this Notice of Funding Opportunity remain the same.

Inquiries

Please direct all inquiries to:

Mercedes Rubio, PhD
National Institutes of General Medical Sciences (NIGMS)
Email: [email protected]